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Abstract
This is a case presentation of a 26-year-old woman with a moderate-sized atrial septal secundum defect (17mm) who un-
derwent catheterism, during which an Amplatzer Septal Occluder number 26 was inserted successfully. On the second postopera-
tive day, she deteriorated and a clinical examination showed a typical tamponade. After a percutaneous aspiration of the pericar-
dial cavity and transient improvement in vital signs, a pig-tail catheter was inserted percutaneously emergently, and the patient was 
transferred to the operating room in a preshock state. During the operation, an active bleeding point in the superoanterior aspect 
of the right atrium near the aortic root was detected, which was repaired by direct suture and pericardial patch reinforcement. The 
Amplatzer device was removed and the atrial septal defect was repaired with a pericardial patch. 
A lethal complication of the interventional closure of atrial septal defect, properly treated by an emergent intervention and 
operation, is presented and discussed herein.
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Introduction
Atrial septal defect (ASD) is a prevalent congenital heart 
disease (3.78 per 10000 live births).1 Surgical treatment is 
safe and effective, but there are complications related to 
thoracotomy, bleeding, arrhythmia, post-pericardectomy 
syndrome, and residual defects.1 Over the years, various 
devices have been utilized for the closure of ASDs by 
interventional pediatric cardiologists. The concept of the 
ASD closure device was first introduced by Ring et al. in 
1976.2  The devices usually used for ASD closure are the 
CardioSEAL Septal Occluder, Amplatzer Septal Occluder 
(ASO), and Das-AngelWings Septal Occluder.2 The ASO 
is a device approved by the FDA for the transcatheter 
closure of secundum ASDs and fenestrations of the Fontan 
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operation.3,4
The ASO is a self-expandable, double-disc device made 
from a Nitinol wire mesh.  Nitinol is a metal alloy used in 
many medical appliances. The two discs are linked together 
by a short connecting waist corresponding to the size of the 
ASD. Its closing ability is normally increased by filling the 
discs and the waist with polyester fabric.3
Case report
A 26-year-old woman with symptoms of palpitation and 
dyspnea on exertion was referred for ASD closure with 
the ASO. She had normal sinus rhythm on her ECG and 
a normal chest X-ray. Transthoracic and transesophageal 
echocardiography revealed a moderate-sized ASD 
(secundum type) 17mm in size as well as left-to-right shunt, 
Qp/Qs=1.8, anterosuperior rim: 2mm, posteroinferior rim: 
16 mm, anteroinferior rim: 7-8mm, posterosuperior rim: 
11mm, superior rim: 10mm, inferior rim: 19mm, and ejection 
fraction: 50%.
The patient underwent catheterism and received heparin 
(7500 units intravenous). The patient’s activated clotting 
time was not checked. An ASO number 26 was inserted 
successfully for the closure of the defect, and balloon 
sizing was performed. Transesophageal echocardiography 
was not available during the procedure. Aspirin and Plavix 
were prescribed for the patient after the procedure. She 
was in good physical condition for 2 days, but then a mild 
pericardial effusion was detected, which was confirmed by 
echocardiography. The effusion suddenly deteriorated, and 
the patient’s blood pressure decreased and her pulse rate 
increased. Echocardiography showed severe pericardial 
effusion. Before long, she was in shock. The clinical impression 
being that of cardiac tamponade, percutaneous aspiration of 
the pericardial cavity was performed, which led to a transient 
improvement in the patient’s vital signs. Emergently, a pig-
tail catheter was inserted percutaneously. On account of the 
fact that the patient was bleeding continuously and was in a 
preshock state, she was transferred to the operating room, 
where via a mid-sternotomy incision her pericardial cavity 
was exposed and copious amounts of blood were aspirated. 
An active bleeding point in the superoanterior aspect of the 
right atrium adjacent to the aortic root was detected (Picture 1). 
Picture 1. Proximity and probable erosion of posterior side of aortic root (arrow)
Cannulation of the aorta, superior vena cava and inferior 
vena cava was carried out after cardiopulmonary bypass 
had been established. The right atrium was opened, and 
the ASO was pulled back in its sheath and removed by the 
interventionist (Picture 2).
Picture 2.  Perforation site (arrow)
The ASD was repaired using  a pericardial patch, and  the 
right  atrial  perforation  was repaired  by  direct  suture 
and  pericardial patch  reinforcement. Cardiopulmonary 
bypass and, subsequently, the operation were terminated 
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uneventfully. After a normal and uneventful postoperative 
course, the patient was discharged from hospital in good 
general condition.
Discussion
Reports from different parts of the world indicate that the 
ASO-associated cardiac perforation is a rare complication 
which uniquely involves the anterosuperior atrial walls 
and the adjacent aorta. Despite a great deal of research, the 
pathophysiology of this complication has hitherto remained 
poorly understood.4,5 It is worthy of note that the fistulisation 
of different cardiac chambers has also been reported.6 As 
reported in the literature, our patient had perforation in the 
anterosuperior aspect of her right atrium. There are reports 
of early as well as late perforations by the ASO.7,8 Patients 
with deficient aortic rims and/or superior rims may be at 
higher risk of device erosion.9,10,11 In our case, however, it 
seems that the rim was sufficient and a deficient rim cannot 
be blamed for the erosion. Oversized ASOs may increase the 
risk of erosion, and a device to the defect ratio of 1:1 or a 
device 10-20% larger than invasively measured stretched 
defect diameter should be chosen and implanted on the 
basis of the intracardiac echocardiographic data. 9,12,13 The 
defect should not be overstretched during balloon sizing,9 
and the reason for cardiac perforation in our case must have 
been a mismatch between the size of the defect and that of 
the device; in other words the insertion of a large device 
in a small ASD. Morphologic variations of the ASD are 
common. Transthoracic echocardiography supplemented 
with transesophageal echocardiography is crucial for the 
determination of the ASD morphologic features, diameter, 
and rims, which are crucial for proper patient selection. 
Transesophageal echocardiography allows precise guiding 
and positioning of the ASO, which is essential for a safe and 
effective transcatheter ASD closure.11,14 In our patient, the 
catastrophic perforation must have occurred 2 days after the 
procedure because during the first 2 post-intervention days 
there were no abnormal findings other than mild pericardial 
effusion. This is a point to ponder; indeed the fact that such 
delayed catastrophic events may occur after such procedures 
renders a close observation of the patients, even those in 
whom the immediate results are promising, mandatory.
Conclusion
Cardiac perforation following ASD closure with the ASO 
is a rare complication.  Transesophageal echocardiography 
during the interventional procedure may reduce the incidence 
of this complication in as much as it affords a better view of 
the defect rims, thereby avoiding a mismatch between the 
size of the device and that of the ASD.
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